Health Technology

Presidio Medical™ Announces Executive Appointment

Retrieved on: 
Tuesday, March 21, 2023
Science, Cardiology, Other Science, Health, Medical Devices, Health Technology, Clinical Trials, Other Health, R&D, ULF, DME, Presidio, SJM, Program management, Cardiac resynchronization therapy, Organization, Development, Senior, Durable medical equipment, Acquisition, Divisional patent application, Supply chain, Patient, Ultra, Heart failure, Growth, Chronic pain, St. Jude Medical, Medical device, Management, Operation

Presidio Medical, Inc., a clinical-stage medical device company developing a transformational Ultra Low Frequency (ULF™) neuromodulation platform, announced that Scott Salys joined the Executive Team as Chief Research & Development and Operations Officer.

Key Points: 
  • Presidio Medical, Inc., a clinical-stage medical device company developing a transformational Ultra Low Frequency (ULF™) neuromodulation platform, announced that Scott Salys joined the Executive Team as Chief Research & Development and Operations Officer.
  • Mr. Salys joins Presidio from Abbott where he was most recently the Divisional Vice President of R&D of the Heart Failure business.
  • “We are thrilled to have someone with Scott’s breadth of experience across Operations, Supply Chain, and R&D join the Presidio team.
  • “I am excited to join this incredibly talented team and lead Presidio Medical through the next stage of clinical and product development.

ShiftKey & OnShift Launch Transformative System for Healthcare Facilities, the Schedule Automation Marketplace Integration “SAMI”

Retrieved on: 
Tuesday, March 21, 2023
Other Technology, Software, Human Resources, Networks, Internet, Consulting, Hardware, Hospitals, Electronic Design Automation, Data Management, Professional Services, Technology, Mobile, Wireless, Managed Care, Data Analytics, Health, Apps, Applications, Health Technology, Workforce, SAMI, Partnership, Patient, Management, Nursing

ShiftKey and OnShift today announced the launch of the Schedule Automation Marketplace Integration (SAMI), a first-of-its-kind system that combines the full power of ShiftKey’s workforce marketplace and OnShift’s dashboard view and data, empowering facilities with the resources and insights to make strategic workforce decisions in the short and long-term.

Key Points: 
  • ShiftKey and OnShift today announced the launch of the Schedule Automation Marketplace Integration (SAMI), a first-of-its-kind system that combines the full power of ShiftKey’s workforce marketplace and OnShift’s dashboard view and data, empowering facilities with the resources and insights to make strategic workforce decisions in the short and long-term.
  • “I’m thrilled to unveil SAMI in partnership with OnShift.
  • It’s a win for everyone.”
    The integration comes at no additional cost for facilities using the ShiftKey and OnShift platforms.
  • For more information on the SAMI product, or to schedule a demo, please visit: https://www.shiftkey.com/sami/ .

51 Million Americans Were Affected by Healthcare Data Breaches in 2022 Due to Weak Security

Retrieved on: 
Tuesday, March 21, 2023
Data Management, Security, Health, Technology, Health Technology, Practice Management, Office of Inspector General, U.S. Department of Health and Human Services, AT&T, Human services, Health care, Importance, Smart meter, Investment, Remote patient monitoring, Switch, RPM, Medical device

The paper "The Importance of Health Data Security Workflows in Remote Patient Monitoring and Remote Therapeutic Monitoring" reviews emerging data security threats from overseas monitoring device vendors and the associated costs of exposing patient data to security breaches.

Key Points: 
  • The paper "The Importance of Health Data Security Workflows in Remote Patient Monitoring and Remote Therapeutic Monitoring" reviews emerging data security threats from overseas monitoring device vendors and the associated costs of exposing patient data to security breaches.
  • According to recent data released by the Department of Health and Human Services, more than 51 million people in the U.S. were affected by healthcare data breaches in 2022.1 The Smart Meter guidance discusses emerging threats and best practices of standard security protocols that RPM companies should consider when evaluating their vendors and data networks regarding patient-generated health data security.
  • Successful, trusted device and data vendors follow best practices in data security to ensure RPM companies do not suffer the potential business continuity issues associated with security breaches.
  • Download a copy of the health data security workflows paper here .

Particle Health Launches Suite of Solutions Built to Wrangle Data for Seven Disease States and Make Actionable Patient Health Information a Reality

Retrieved on: 
Tuesday, March 21, 2023
Technology, Diabetes, Health, Other Health, Pharmaceutical, Oncology, Physical Therapy, Software, Infectious Diseases, General Health, Health Technology, Data Management, Clinical Trials, Cardiology, FOCUS, ICD-10, FHIR, Organization, LOINC, RxNorm, Particle, Patient, RLS, Knowledge, Usability, Chronic kidney disease, CKD, Roger Hawkins (drummer), Nursing, Orthopedic surgery, Gastroenterology

Particle Health , an interoperability platform that aggregates and delivers actionable patient data and insights to healthcare companies, announced it has launched its Particle FOCUS (Filtered Outputs Curated for Usability + Simplicity) solution suite.

Key Points: 
  • Particle Health , an interoperability platform that aggregates and delivers actionable patient data and insights to healthcare companies, announced it has launched its Particle FOCUS (Filtered Outputs Curated for Usability + Simplicity) solution suite.
  • FOCUS data products are designed to streamline data by delivering comprehensive, simplified, and organized patient health information across seven disease states: Diabetes, Cardiology, Oncology, Chronic Kidney Disease (CKD), Pulmonology, Orthopedics, and Gastroenterology.
  • This is made possible because FOCUS products have the flexibility to integrate into pre-existing workflows, delivering turnkey data and key drivers across seven high-cost medical conditions.
  • "Particle FOCUS has created a way for digital health organizations to skip the most expensive steps of achieving value from an interoperability vendor.

Alveo Technologies Announces ISO 13485:2016 Certification

Retrieved on: 
Tuesday, March 21, 2023
Technology, Medical Devices, General Health, Infectious Diseases, Other Natural Resources, Veterinary, FDA, Agriculture, Natural Resources, COVID-19, Wearables, Mobile Technology, Health, Health Technology, Other Technology, Other Health, Hardware, Data Management, IVDR, QMS, ISO, Aquaculture, Infection, COVID-19 testing, Quality, Certification, GMED, European, IVD, Diagnosis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, International Organization for Standardization, Farm, Medical device, EU, Alveo Financial Tower

Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.

Key Points: 
  • Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today announced its quality management system (QMS) has achieved ISO 13485:2016 certification for the design, development and manufacture of in vitro diagnostic kits and analyzers for the detection of infectious disease.
  • Compliance with the ISO 13485 standard is required for companies to market medical devices in many markets, including the European Union, Canada, Japan, and Australia.
  • In addition, the U.S. Food and Drug Administration has announced plans to harmonize its existing medical device QMS requirements with ISO 13485, proposing new regulations that incorporate ISO 13485 as the foundational requirements.
  • “We are thrilled to achieve ISO 13485 certification,” says Alveo CEO Shaun Holt.

Potomac Urology Achieves Growth with eClinicalWorks EHR and healow Patient Engagement Solutions

Retrieved on: 
Tuesday, March 21, 2023
Software, Managed Care, Networks, General Health, Internet, Data Management, Apps, Applications, Technology, Artificial Intelligence, Health Technology, Practice Management, Health, Cloud, Online, Patient satisfaction, UTI, BPH, Progress, Multimedia, Patient portal, MD, EHR, Patient, Physician, Combat, Roger Hawkins (drummer), Memory, Female, Scribe, Nursing, Medical imaging, Medical device

eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Potomac Urology, a Northern Virginia-based urology practice, is expanding to a new office location in Fair Oaks, VA with the help of the eClinicalWorks Cloud EHR and healow patient engagement solutions.

Key Points: 
  • eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Potomac Urology, a Northern Virginia-based urology practice, is expanding to a new office location in Fair Oaks, VA with the help of the eClinicalWorks Cloud EHR and healow patient engagement solutions.
  • Potomac Urology will continue to offer state-of-the art urologic care while leveraging advanced technology to mitigate physician burnout and improve patient satisfaction.
  • As Potomac Urology continues to expand, the practice will leverage the following solutions to improve patient engagement and physician satisfaction:
    eClinicalWorks Scribe®: Scribe, an AI-driven speech-to-text-technology, helps Potomac Urology save time while keeping medical records accurate.
  • With healow Open Access, Potomac Urology is expediting patient care, improving patient experience and satisfaction, and reducing no-shows.

Gozio Health Expands Platform to Enable Customized Experiences by User Type

Retrieved on: 
Tuesday, March 21, 2023
Apps, Applications, Technology, Mobile, Wireless, Hospitals, Health Technology, Software, Practice Management, Managed Care, Health, AMA, Burnout, ViVe, UNC Health Care, Hospital, Patient, UNC, Job satisfaction, Nursing, Qualtrics

Gozio Health , an industry-leading, customizable, location-aware mobile engagement platform, today announced new capabilities that allow hospitals and health systems to provide custom mobile experiences by user type or group.

Key Points: 
  • Gozio Health , an industry-leading, customizable, location-aware mobile engagement platform, today announced new capabilities that allow hospitals and health systems to provide custom mobile experiences by user type or group.
  • Importantly, to maximize engagement and opportunities to connect staff and patients, these experiences can now happen in one platform.
  • However, to ensure that these user-based experiences bring together necessary digital solutions, Gozio is also opening its platform to third-party development.
  • “While customized mobile experiences come in many forms, the number one request we receive now is, unsurprisingly, related to staff.

athenahealth Enhances its Marketplace Program to Strengthen Customer and Partner Success

Retrieved on: 
Tuesday, March 21, 2023
Software, Networks, Health, Data Management, Health Technology, Technology, Apps, Applications, Other Health, Business development, Marketplace, EVP, Athenahealth, Stevie Awards, Patient, Customer service, Gold, D&I, Customer, RPM, Syndrome, Automation, D, Nursing, Online shopping, Privia

Partner tiering and an Accelerate Partner Program that helps customers distinguish which partner solutions are most adopted and highly rated by similar practices and specialties.

Key Points: 
  • Partner tiering and an Accelerate Partner Program that helps customers distinguish which partner solutions are most adopted and highly rated by similar practices and specialties.
  • A new Marketplace Diversity and Inclusion (D&I) Program, which recognizes valuable partnerships with minority-, woman-, LGBTQ-, disability-, and veteran-owned businesses.
  • A personalized Marketplace Partner Resource Hub for easy access to program resources, customer leads, and account management tools.
  • Further, over 71% of athenahealth customers have adopted Marketplace partner solutions, with thousands of new connections each year.

OcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity

Retrieved on: 
Tuesday, March 21, 2023
Biotechnology, Technology, Diabetes, Health, General Health, Optical, Health Technology, Medical Devices, Research, Software, Science, FPF, Retina, Glaucoma, New York Eye and Ear Infirmary, Institutional review board, Ranibizumab, Cell death, RVO, AMD, Visual impairment, DR, CSR, Mitochondrial disease, Retinal, Publication, Vance DeGeneres, Apoptosis, Sickle cell disease, Macular edema, Diabetic retinopathy, Patient, Frontiers Media, Disease, Medical imaging, Ophthalmology

OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal.

Key Points: 
  • OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal.
  • By assessing the flavoprotein fluorescence in the retina with its flagship device, the OcuMet Beacon, these findings suggest that the novel FPF measure can detect retinal diseases with a high degree of sensitivity.
  • Mitochondrial dysfunction has been documented as a precursor to apoptosis, or cell death, and is implicated in many retinal diseases and disorders.
  • The OcuMet Beacon is currently being used under Institutional Review Board at New York Eye and Ear Infirmary at Mount Sinai.

Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm

Retrieved on: 
Tuesday, March 21, 2023
Technology, Medical Devices, Health Technology, Cardiology, Software, Biotechnology, Health, General Health, Artificial Intelligence, Heart, Communication, Abdominal aortic aneurysm, Pulmonary embolism, AAA1, Food and Drug Administration, Aortic rupture, Intelligence, CTA, Multimedia, Risk, TriHealth, Viz, Death, Hospital, Triage, Rupture, AAA, MD, Patient, Physician, Blood, Korea Disease Control and Prevention Agency, Artificial intelligence, AI, FDA, Computed tomography angiography, Food, Disease, Medical device, Medical imaging

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA).

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA).
  • The new artificial intelligence (AI) algorithm and clinical workflow solution will be a part of the VizTM AORTIC Module, an AI solution designed to accelerate treatment decisions for all aortic pathology.
  • An abdominal aortic aneurysm is a bulge in the abdominal aorta, the main artery that carries blood from the heart to the rest of the body.
  • Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.